
    
      The development of newer technologies has allowed clinicians and researchers to better
      understand pathophysiological underpinnings of different disorders managed with
      neuromodulation. The is now the ability to stream brain signals from a newly FDA approved
      device, the Medtronic Percept. The investigators will study the longitudinal effects of DBS
      on the brain signals that are found to correlate with tremor severity as measured with
      wireless wearable sensors.
    
  